Homepage

Latest articles

• 2025-12-10

  Untreated Sleep Apnea May Double Parkinson’s Disease Risk

  A massive new study involving over 11 million people has uncovered a concerning link between Obstructive Sleep Apnea (OSA) and Parkinson’s disease. However, the research also offers a silver lining: consistent CPAP therapy may significantly reverse this risk.

• 2025-12-08

  ResMed Revolutionizes CPAP Therapy with First-of-its-Kind FDA Clearance for AI ‘Smart Comfort’ Technology

  Date: December 8, 2025 | Topic: CPAP Technology / ResMed News / CPAPeuropa In a major leap forward for personalized sleep medicine, ResMed (NYSE: RMD) announced today that it has secured FDA clearance for its innovative Smart Comfort feature. This marks a historic moment in the industry, as Smart Comfort becomes the first FDA-cleared medical […]

• 2025-11-17

  AirTouch N30i by Resmed: The Complete In-Depth Review

    In the constantly evolving landscape of sleep apnea therapy, true innovation often comes in the form of subtle yet profound changes that redefine user comfort. For years, CPAP users have sought a mask that balances a secure seal with a barely-there feel. Today, that search may be over. Resmed, the global leader in sleep […]

• 2025-11-13

  Oniris Classic vs. Oniris Plus: A Brief Comparison

    Snoring and mild to moderate sleep apnea can significantly disrupt sleep quality—both for you and your partner. Mandibular advancement devices, like those in the Oniris series, are a clinically proven, effective, and non-invasive solution. But when you are faced with a choice between two models, it’s important to know the key differences to make […]